Statistics for Application of an active comparator-based benefit-risk Assessment in evaluating clinical trial design features of a new chemical entity using a Bayesian decision-theoretic framework.

Total visits

views
Application of an active comparator-based benefit-risk Assessment in evaluating clinical trial design features of a new chemical entity using a Bayesian decision-theoretic framework. 191

Total visits per month

views
May 2024 1
June 2024 0
July 2024 0
August 2024 1
September 2024 2
October 2024 0
November 2024 0

File Visits

views
Goel_umn_0130E_11194.pdf 530

Top country views

views
United States 93
China 18
France 17
Germany 12
Canada 5
United Kingdom 5
Ireland 4
Hong Kong SAR China 3
Finland 2
India 2
Iran 2
Netherlands 2
Russia 2
Singapore 2
Taiwan 2
Ukraine 2
Argentina 1
Belgium 1
Georgia 1
Indonesia 1
Italy 1
South Korea 1
Mongolia 1
Malaysia 1
Pakistan 1
Romania 1
South Africa 1
Zambia 1

Top city views

views
Redmond 20
Ashburn 9
Minneapolis 9
New York 9
Montréal 4
Mountain View 4
Beijing 3
Dublin 3
Shenzhen 3
Changsha 2
Chicago 2
Fairfax 2
Gilbert 2
London 2
Minneapolis (Prospect Park) 2
Newark 2
Newton 2
Secaucus 2
Tianjin 2
Annandale 1
Bad Homburg 1
Boardman 1
Brooklyn 1
Buffalo 1
Bushehr 1
Cape Town 1
Cary 1
Central 1
Cheltenham 1
Den Haag 1
Des Moines 1
Dongguan 1
Fremont 1
Glenside 1
Hinckley 1
Islamabad 1
Jakarta 1
Las Vegas 1
Melrose 1
Nanjing 1
New Hope 1
Newtonville 1
North Chicago 1
Pensacola 1
Pullman 1
Royersford 1
Saint Paul 1
Saint Petersburg 1
Shah Alam 1
Shanghai 1
Silver Spring 1
Singapore 1
Staten Island 1
Taichung 1
Taipei 1
Tbilisi 1
Tehran 1
Tokyo 1
Vladivostok 1
Wako 1
Walnut 1
Zhengzhou 1